ClinicalTrials.gg
Enrolling by invitationNCT05982028Updated Aug 8, 2023

Patients' Quality of Life After Pilonidal Cyst Operations.

An interventional study of Minimally invasive pit-picking surgery and Radical surgical excision without suturing in Pilonidal Cyst, Pain Postoperative and Quality of Life, sponsored by Lithuanian University of Health Sciences. Enrolling by invitation at 1 site in Lithuania. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-08-08.

Sponsored by Lithuanian University of Health Sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as enrolling by invitation.
  • Registered 2 years 10 months after the study started (first participant enrolled Sep 2020, registered Jul 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Biomedical research consists of two main parts. In the first part, the pilonidal cyst-specific quality of life questionnaire is compiled, adapted, validated, tested for suitability in assessing patients after pilonidal cyst operations.

The second part will compare two pilonidal cyst operations. A prospective, comparative, randomized clinical study will be conducted.

Read the detailed description

The first part includes the creation, adaptation, validity and suitability of the pilonidal cyst-specific quality of life questionnaire in assessing patients after pilonidal cyst operations, verification and evaluation of the quality of life and its dynamics after these operations. A survey of patients operated on for acute and chronic pilonidal cysts will be conducted. The main evaluation criteria of the first part will be the internal consistency of the questionnaire, the stability of the measurements, the construct validity and the frequency of patients with moderate and severe symptoms according to the specific quality of life questionnaire after pilonidal cyst surgery and the SF36v2 quality of life questionnaire.

The second part will compare two pilonidal cyst operations. A prospective, comparative, randomized clinical study will be conducted. This part of the study will study patients scheduled for surgery for chronic pilonidal cyst. Patients will be randomized into two groups, a group that will undergo radical excision of the pilonidal cyst without suturing the wound and a group that will undergo minimally invasive "pit picking" surgery. Patients will be interviewed before surgery, as well as on the first and second day after surgery. Discharged patients will complete quality-of-life questionnaires at 1, 2 weeks, and 2 months. Patients will be invited for a visit after 1 and 6 months, wound healing, disease recurrence and quality of life will be evaluated. The main evaluation criteria of the second part will be objective data - postoperative complications, wound healing time, duration of incapacity for work, frequency of disease recurrence and subjective data - changes in pain (VAS 10 cm scale) and quality of life total points according to SF36v2 and the specific life questionnaire created after radical pilonidal cyst excision and "pit picking" operations.

02

Conditions studied

  • Pilonidal Cyst
  • Pain Postoperative
  • Quality of Life
03

In context

Pilonidal Sinus

109 studies on the registry are indexed under Pilonidal Sinus; 32 are open to participants now.

This study's planned enrollment of 100 is above the median of 80 across 72 interventional studies indexed under Pilonidal Sinus.

Browse Pilonidal Sinus studies →

Lead sponsor

Lithuanian University of Health Sciences is the lead sponsor of 105 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients aged 18-75 (men and women)
  2. Chronic symptomatic (primary or recurrent) pilonidal cyst
  3. physical status I to III
  4. Signed the person's information and consent form to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. Acute pilonidal cyst
  2. Patients who do not speak Lithuanian
  3. Cognitive, visual, auditory and locomotor system disorders
  4. Insufficiency of kidneys, liver, cardiopulmonary system
  5. Refuses to participate in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Pit picking group

    Minimally invasive pilonidal cyst surgery.

    Procedure: Minimally invasive pit-picking surgery

  • Experimental
    Excision group

    Radical surgical pilonidal cyst excision without suturing

    Procedure: Radical surgical excision without suturing

Interventions

  • ProcedureMinimally invasive pit-picking surgery

    Midline pits and secondary fistula openings were probed to determine the direction and length of any associated sinus tracts, followed by an excision with a 3 or 5 mm punch biopsy needle, depending on the size of the pit. A 2 cm lateral incision was made parallel to the pilonidal cyst. Hair and granulations within the sinus tracts were removed, and the cyst cavity was drained through the incision. Nonabsorbable monofilament sutures were used to close the excisional wounds of the pits and secondary fistula. Once haemostasis was achieved, the wound was covered with a sterile gauze with 10 % povidone-iodine solution.

  • ProcedureRadical surgical excision without suturing

    Under the guidance of brilliant green, the cavity of the pilonidal cyst, along with the sinus tracts and fistulas, was marked. A symmetric elliptical incision was made to excise the pits and secondary fistula openings. The pilonidal cyst was removed from the healthy subcutaneous tissue and sacrococcygeal fascia using monopolar electrocautery. The wound was not sutured and was left open to heal by secondary intention. After haemostasis was achieved, the wound was covered with sterile gauze with 10 % povidone-iodine solution.

06

What researchers measure

Primary outcomes

  1. Pain after surgery

    Postoperative pain will be assessed on a VAS 100 mm scale. Patients will mark their pain at rest on a specified 100 mm scale at the specified time.

    Time frame: One week after surgery

Secondary outcomes

  1. Rate of disease recurrence

    Disease recurrence will be assessed by clinical examination.

    Time frame: Recurrence will be assessed 6 months and 2 years after surgery

  2. Pain after surgery

    Postoperative pain will be assessed on a VAS 100 mm scale. Patients will mark their pain

    Time frame: One day after surgery

  3. Pain after surgery

    Postoperative pain will be assessed on a VAS 100 mm scale. Patients will mark their pain

    Time frame: Two days after surgery

  4. Pain after surgery

    Postoperative pain will be assessed on a VAS 100 mm scale. Patients will mark their pain

    Time frame: Two weeks after surgery

  5. Pain after surgery

    Postoperative pain will be assessed on a VAS 100 mm scale. Patients will mark their pain

    Time frame: One month after surgery

  6. Pain after surgery

    Postoperative pain will be assessed on a VAS 100 mm scale. Patients will mark their pain

    Time frame: Two months after surgery

  7. Pain after surgery

    Postoperative pain will be assessed on a VAS 100 mm scale. Patients will mark their pain

    Time frame: Six months after surgery

Other outcomes

  1. Postoperative complications

    Patients will report past complications.

    Time frame: 1 months after surgery

  2. Quality of life according to the 36-Item Short Form Survey (SF-36).

    Patients fill out the the 36-Item Short Form Survey (SF-36). All questions are scored on a scale from 0 to 100, with 100 representing the highest level of functioning possible. Aggregate scores are compiled as a percentage of the total points possible, using the RAND scoring table. The scores from those questions that address each specific area of functional health status are then averaged together, for a final score within each of the 8 dimensions measured (physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/ fatigue, emotional well being, social functioning, pain, general health). All 8 categories are scored in the same way.

    Time frame: Before surgery, 1 and 2 days after surgery, 1 and 2 weeks after surgery, 1, 2 and 6 months after surgery. Change from baseline in quality of life scores over a 6-month period will be assessed.

  3. Duration of disability

    Patients will note the duration of incapacity for work.

    Time frame: 1 month after surgery

  4. Wound healing time

    Patients will note the time when the wound healed.

    Time frame: Six months after surgery

  5. Quality of life total scores according to a specific life questionnaire developed by the researcher.

    Patients fill out a specific life questionnaire. This questionnaire consists of 20 questions, the value of each question is from 1 to 5 points. The minimum score value is 20, the maximum score value is 100. A lower score value indicates a better quality of life.

    Time frame: Before surgery, 1 and 2 days after surgery, 1 and 2 weeks after surgery, 1, 2 and 6 months after surgery. Change from baseline in quality of life scores over a 6-month period will be assessed.

07

Study locations

1 site
  • Lithuanian University of Health Sciences, Clinic of General Surgery
    Kaunas, LT-47144, Lithuania
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2020 (actual). Primary completion is estimated for Sep 2024, 48 months after the start.

Of 35 interventional studies with no phase under Pilonidal Sinus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 48 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2023
First posted
Aug 8, 2023
StartActual
Sep 1, 2020
Primary completionEst.
Sep 1, 2024
CompletionEst.
Mar 1, 2025
Last update
Aug 8, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05982028
Responsible party
Edvinas Dainius (Principal Investigator, Lithuanian University of Health Sciences) — Principal investigator
First posted
Aug 8, 2023
Start date
Sep 1, 2020
Primary completion
Sep 1, 2024 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Aug 8, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion